4539.T
NIPPON CHEMIPHAR CO.,LTD.
スタンダード · 医薬品 · 医薬品 · JP
JPY 1,569.00
−1.94%Year over year
Reported trailing growth
- Revenue
- +1.7%
- EBITDA
- —
- EBIT
- +544.7%
- EPS
- +318.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +3.0%
- EBITDA
- —
- EPS
- -72.5%
Three-year CAGR
- Revenue
- +0.1%
- EBITDA
- -6.3%
- EBIT
- -9.8%
- Net income
- -25.1%
- EPS
- -25.1%
- Free cash flow
- +20.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026